PH25296A - Pharmaceutical formulation containing indomethacin - Google Patents

Pharmaceutical formulation containing indomethacin

Info

Publication number
PH25296A
PH25296A PH8735058A PH35058A PH25296A PH 25296 A PH25296 A PH 25296A PH 8735058 A PH8735058 A PH 8735058A PH 35058 A PH35058 A PH 35058A PH 25296 A PH25296 A PH 25296A
Authority
PH
Philippines
Prior art keywords
pharmaceutical formulation
formulation containing
containing indomethacin
indomethacin
carboxylic acid
Prior art date
Application number
PH8735058A
Other languages
English (en)
Inventor
Kim Drummon Rainsford
Michael Wellesley Whitehouse
Original Assignee
Kim Drummon Rainsford
Whitehouse Michael W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Drummon Rainsford, Whitehouse Michael W filed Critical Kim Drummon Rainsford
Publication of PH25296A publication Critical patent/PH25296A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH8735058A 1986-03-27 1987-03-20 Pharmaceutical formulation containing indomethacin PH25296A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868607662A GB8607662D0 (en) 1986-03-27 1986-03-27 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
PH25296A true PH25296A (en) 1991-04-30

Family

ID=10595349

Family Applications (1)

Application Number Title Priority Date Filing Date
PH8735058A PH25296A (en) 1986-03-27 1987-03-20 Pharmaceutical formulation containing indomethacin

Country Status (17)

Country Link
US (1) US4885279A (fr)
EP (1) EP0239332B1 (fr)
JP (1) JPS6322017A (fr)
AT (1) ATE60993T1 (fr)
AU (1) AU593084B2 (fr)
CA (1) CA1285488C (fr)
DE (1) DE3768110D1 (fr)
DK (1) DK154887A (fr)
ES (1) ES2038658T3 (fr)
GB (1) GB8607662D0 (fr)
GR (1) GR3001520T3 (fr)
IE (1) IE59636B1 (fr)
NO (1) NO871187L (fr)
NZ (1) NZ219717A (fr)
PH (1) PH25296A (fr)
PT (1) PT84580B (fr)
ZA (1) ZA872137B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321655D0 (en) * 1993-10-20 1993-12-08 Glyzinc Pharma Ltd Pharmaceutical formulation of aspirin and salicylates
US5518738A (en) * 1995-02-09 1996-05-21 Nanosystem L.L.C. Nanoparticulate nsaid compositions
DE10352511A1 (de) * 2003-11-07 2005-06-16 Ernst-Moritz-Arndt-Universität Greifswald Verwendung von MRP4-Inhibitoren zur Behandlung und/oder Prophylaxe kardiovaskulärer Erkrankungen
HU231309B1 (hu) 2014-02-25 2022-11-28 Darholding Kft. Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (fr) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention des lesions gastriques
AU511852B2 (en) * 1977-11-09 1980-09-11 Australian National University, The Formulating aspirin andthe like
DE2966867D1 (en) * 1979-01-12 1984-05-10 Univ Australian Protection of the gastric mucosal lining from damage by aspirin and related drugs
US4228161A (en) * 1979-03-28 1980-10-14 Merck & Co., Inc. Anti-inflammatory combination having reduced ulcerogenicity
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
GB2155329A (en) * 1984-03-08 1985-09-25 Kim Drummond Rainsford A pharmaceutical formulation containing azapropazone
ATE57472T1 (de) * 1984-03-14 1990-11-15 Jerome Corbiere Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
DE3587151T2 (de) * 1984-12-20 1993-07-15 Sandoz Ag Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.

Also Published As

Publication number Publication date
JPS6322017A (ja) 1988-01-29
GR3001520T3 (en) 1992-11-23
IE59636B1 (en) 1994-03-09
ZA872137B (en) 1987-10-28
ATE60993T1 (de) 1991-03-15
DK154887A (da) 1987-09-28
NO871187L (no) 1987-09-28
DE3768110D1 (de) 1991-04-04
NO871187D0 (no) 1987-03-23
EP0239332A2 (fr) 1987-09-30
US4885279A (en) 1989-12-05
JPH0572887B2 (fr) 1993-10-13
GB8607662D0 (en) 1986-04-30
EP0239332B1 (fr) 1991-02-27
CA1285488C (fr) 1991-07-02
NZ219717A (en) 1989-06-28
AU593084B2 (en) 1990-02-01
IE870742L (en) 1987-09-27
PT84580A (en) 1987-04-01
PT84580B (pt) 1989-11-30
AU7071387A (en) 1987-10-01
EP0239332A3 (en) 1988-03-02
ES2038658T3 (es) 1993-08-01
DK154887D0 (da) 1987-03-26

Similar Documents

Publication Publication Date Title
AU653026B2 (en) Physiologically active polypeptide-containing pharmaceutical composition
MY102459A (en) Oral sustained release pharmaceutical preparation.
AU528190B2 (en) Device for oral administration of drugs to ruminant animals
DE3686936T2 (de) Am zielorgan wirkendes enterales abgabesystem.
AU7960287A (en) Prodrug derivatives of carboxylic acid drugs
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
EP0451750A3 (en) Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients
PH25296A (en) Pharmaceutical formulation containing indomethacin
EP0471388A3 (fr) Médicament pour le traitement de l'insuffisance cardiaque
EP0228239A3 (en) Preparation of a medicament for arthritis and rheumatism
IT1131822B (it) Anilidi di acidi (3-alchilamminio-2-idrossipropossi)-furan-2-carbossilici e loro sali di addizione con acidi compatibili dal punto di vista fisiologico e procedimento per la loro preparazione e anche prodotti medicinali che contengono questi composti
DE3265827D1 (en) Pharmaceutical composition of phosphonomicin in tablet form
EP0272057A3 (fr) Compositions pharmaceutiques contenant des pyranoquinoléines
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
SE8800888L (sv) Foerfarande foer framstaellning av ett laekemedelspreparat foer foerebyggande och behandling av alkoholism